(1) Background: Adiponectin is an adipocyte-secreted hormone that has antidepressant- and anxiolytic-like effects in preclinical studies. Here, we investigated the antidepressant- and anxiolytic-like effects of sub-chronic treatment with AdipoRon, an ...
Thomas Ho-Yin Lee +2 more
exaly +3 more sources
Adiponectin receptor agonist, AdipoRon, restores hepatic clock gene expression in PCOS-associated NAFLD [PDF]
Persistent lower levels of adiponectin are associated with hyperandrogenism, predisposing PCOS women to NAFLD. This study elucidated the therapeutic potential of a small molecule adiponectin receptor agonist-AdipoRon, utilizing an in-vivo PCOS rat model ...
Shivam Sharma +3 more
doaj +2 more sources
The adiponectin receptor agonist AdipoRon alleviates lipotoxic injury in LMH cells [PDF]
Avian fatty liver disease is a metabolic disease characterized by hepatocellular steatosis caused by fat deposition due to lipid metabolism disorders in poultry.
Xinhong Luan +8 more
doaj +2 more sources
Protection of goose adiponectin-derived peptide gADP3 on LPS-induced thymus and spleen injury in goose [PDF]
This study aims to evaluate the protective effects of goose-derived adiponectin peptide gADP3 on Lipopolysaccharide (LPS)-induced damage to goose thymus and spleen.
Ben Ma +5 more
doaj +2 more sources
AdipoRon ameliorates vascular endothelial injury in type 2 diabetes mellitus and is associated with suppression of the NLRP3-Caspase-1-GSDMD pyroptosis axis [PDF]
Background AdipoRon is a bioactive synthetic agonist of the adiponectin receptor. It has been demonstrated to improve glucose tolerance and mitigate insulin resistance.
Xiaoming Chen, Yi Yang
doaj +2 more sources
Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy [PDF]
Adiponectin (ApN) is a hormone with potent effects on various tissues. We previously demonstrated its ability to counteract Duchenne muscular dystrophy (DMD), a severe muscle disorder. However, its therapeutic use is limited.
Michel Abou-Samra +9 more
doaj +2 more sources
Therapeutic potential of AdipoRon in cognitive, depressive, and anxiety disorders: a systematic review and meta-analysis [PDF]
Rising cases of cognitive disorders, depression, and anxiety underscore the need for new treatments, given the limited effectiveness and side effects of current options.
Fatemeh Sadat Gheibi +5 more
doaj +2 more sources
Uncovering the connection between obesity and thyroid cancer: the therapeutic potential of adiponectin receptor agonist in the AdipoR2-ULK axis [PDF]
Adiponectin, a unique adipose-derived factor, is significantly downregulated in obesity, making it a crucial target for tumor-related metabolic research.
Changlin Li +5 more
doaj +2 more sources
AdipoRon as a Novel Therapeutic Agent for Depression: A Comprehensive Review of Preclinical Evidence [PDF]
Background/Objectives: Depression is a mood disorder that causes persistent sadness and loss of interest, and its etiology involves a condition known as hypoadiponectinemia, which is prevalent in depressive individuals compared with healthy individuals ...
Lucas Fornari Laurindo +10 more
doaj +2 more sources
Introduction: Obesity and imbalance in lipid homeostasis contribute greatly to heart failure with preserved ejection fraction (HFpEF), the dominant form of heart failure.
Qinfang Qiu
exaly +3 more sources

